June 11, 2026 · Hormone research in paediatrics · DOI: 10.1159/000552855

PREDICTORS OF RESPONSE TO GROWTH HORMONE TREATMENT AND FINAL HEIGHT IN MEDULLOBLASTOMA SURVIVORS

Listen to this summary

The authors investigate the growth characteristics and response to growth hormone treatment (GHT) in survivors of childhood medulloblastoma, aiming to identify factors influencing final height (FH) outcomes. Their findings indicate that a significant majority of patients experience growth retardation and GH deficiency, with early height-SDS at the start of treatment being the key predictor of FH success. The study emphasizes the importance of timely GH deficiency diagnosis and treatment while highlighting concerns regarding the long-term safety of GHT.

Eve Zipporah Stern, Michal Ben-Ami, Yael Levy-Shraga, Amos Toren, Gadi Abebe-Campino, Michal Lurye, Michal Yalon, Dalit Modan-Moses

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play